Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Maximizing Student Diversity in the Biomedical Sciences at Washington University
Phase 1 Study of Autologous Mesenchymal Stem Cell in Multiple System Atrophy
Identifying Regulators of APP Gamma Secretase
Drug Effects on Cocaine Paired Conditioned Reinforcers
Bone Resorption - Immune and Endocrine Relationships
Recently added grants:
Language and cognition after perinatal stroke
Optimal Tissue Engineering Approach for Treating Injured Vocal Folds
Differential Control of Auditory Cortex by Two Populations of Layer 1 Interneurons
Defining the pathological mechanisms of hereditary hearing loss
Chondrocyte-derived bone cells determine the overall pattern of TMJ condyle and contribute to bone remodeling
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67184-3-0-1
Application #
7574882
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Children's Hosp Pittsburgh/Upmc Health Sys
$182,089
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Lakshmanan, Krishnamurti /
$236,644
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant